Everus Construction Group, Inc.
No SEC Form 4 filings for $ECG in the last 30 days.
Everus Construction Group (NYSE: ECG) saw multiple analyst rating and price-target changes in May 2026. Cantor Fitzgerald raised its target to $174 (neutral), Oppenheimer to $180 (outperform), and Stifel Nicolaus set $172 (and earlier $153, buy). Guggenheim upgraded to buy with $160; Freedom Capital downgraded to hold; Zacks downgraded to hold; Glj Research initiated hold at $141.
Everus Construction Group (NYSE: ECG) announced that its President and CEO, Jeffrey S. Thiede, and VP and CFO, Maximillian J Marcy, will attend the KeyBanc Capital Markets Industrials & Basic Materials Conference on May 27 and the Stifel 2026 Cross Sector Insight Conference on June 2, both in Boston. They will be available for one-on-one meetings with investors registered for these events. Everus is an S&P SmallCap 600® index member providing specialized construction services across the U.S.
Everus Construction Group (ECG) reported a strong Q1 2026 with increased revenue and EPS, showcasing improved profitability and firmer margins. While recent performance supports a bullish outlook due to earnings growth and a substantial project backlog, concerns exist regarding its premium P/E ratio compared to peers and a significant gap to its DCF fair value, coupled with forecast growth rates below market averages. Investors are weighing the solid recent profitability against a potentially overvalued stock price and more moderate future growth expectations.
